A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)
- Status
- RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE3
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Mevrometostat With Enzalutamide in People With Prostate Cancer Who Have Previously Received Androgen Receptor Pathway Inhibitor Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
PSMA PET/CT-Based Multimodal Model for Predicting Response to First-Line Therapy in mHSPC.
- Status
- COMPLETED
- Phase
- N/A
A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics
- Status
- RECRUITING
- Phase
- N/A
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of TYK-00540 Combined With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer（mCRPC）
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)
- Status
- COMPLETED
- Phase
- N/A
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Status
- RECRUITING
- Phase
- PHASE3
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
The COSMYC Trial (COmbined Suppression of MYC)
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3